Financials

News Ideas Technicals

8189 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TIANJIN TEDA BIOMEDICAL operating, investing, and financing activities

8189 free cash flow for H2 23 is -17.32 M HKD. For 2023, 8189 free cash flow was -16.99 M HKD and operating cash flow was -14.26 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—